Table 2 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Authors

Publication Details

Published
2025-09-22
DOI
https://doi.org/10.1158/2767-9764.30177709
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Table 2 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Meredith McKean, Vicky Barnhart, Eric Tu, Raymond Mager et al.
Monoclonal and Polyclonal Antibodies Research
article

Table 2 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Meredith McKean, Vicky Barnhart, Eric Tu, Raymond Mager, Martina Imbimbo, Chunling Fan, Carine Paturel, Yun He, Steven Eck, Paula G. Fraenkel, Antoîne Italiano, Elina Murtomaki, Benedito A. Carneiro, Zachary A. Cooper, Patricia Martín-Romano, Teresa Macarulla, Antoine Hollebecque, John D. Powderly, Arsène‐Bienvenu Loembé, Eduardo Castañón Álvarez, Agnes Boyer Chamard
article en

Abstract

No abstract available for this paper.
Openalex Percentile: Top 62%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.